Variant report
Variant | esv2582955 |
---|---|
Chromosome Location | chr5:89860131-89861642 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:89824628..89827035-chr5:89857700..89861051,3 | K562 | blood: | |
2 | chr5:89854731..89856596-chr5:89856787..89860606,4 | K562 | blood: | |
3 | chr5:89857832..89860192-chr5:90676540..90678768,2 | K562 | blood: | |
4 | chr5:89703769..89706239-chr5:89858612..89861256,3 | MCF-7 | breast: | |
5 | chr5:89856963..89860302-chr5:89865083..89868215,3 | MCF-7 | breast: | |
6 | chr5:89854805..89859362-chr5:89860971..89864483,4 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000164199 | chromatin interactions |
ENSG00000176018 | chromatin interactions |
ENSG00000153140 | chromatin interactions |
ENSG00000255647 | chromatin interactions |
ENSG00000113369 | chromatin interactions |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs533904943 | chr5:89860132-89860133 | Enhancers Weak transcription | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
2 | rs35348904 | chr5:89860208-89860209 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
3 | rs547149676 | chr5:89860222-89860223 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
4 | rs567298613 | chr5:89860228-89860229 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
5 | rs558229403 | chr5:89860233-89860234 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
6 | rs536238431 | chr5:89860287-89860288 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
7 | rs556544765 | chr5:89860338-89860339 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
8 | rs143660562 | chr5:89860339-89860340 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
9 | rs187807556 | chr5:89860395-89860396 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
10 | rs34960896 | chr5:89860417-89860418 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
11 | rs200720440 | chr5:89860430-89860431 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
12 | rs202162078 | chr5:89860436-89860437 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
13 | rs200346987 | chr5:89860439-89860440 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
14 | rs201447116 | chr5:89860441-89860442 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
15 | rs202185232 | chr5:89860442-89860443 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
16 | rs202140182 | chr5:89860443-89860444 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
17 | rs201506189 | chr5:89860444-89860445 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
18 | rs1311086 | chr5:89860530-89860531 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
19 | rs1312508 | chr5:89860628-89860629 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
20 | rs1312429 | chr5:89860650-89860651 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
21 | rs375866594 | chr5:89860685-89860686 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
22 | rs538515754 | chr5:89860778-89860779 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
23 | rs201884976 | chr5:89860779-89860780 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
24 | rs111498553 | chr5:89860815-89860816 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
25 | rs572116696 | chr5:89860826-89860827 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
26 | rs146626276 | chr5:89860838-89860839 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
27 | rs139119716 | chr5:89860849-89860850 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
28 | rs143236903 | chr5:89860906-89860907 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
29 | rs116898557 | chr5:89860922-89860923 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
30 | rs372892320 | chr5:89860961-89860962 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
31 | rs563299033 | chr5:89860964-89860965 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
32 | rs111323892 | chr5:89860972-89860973 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
33 | rs79256827 | chr5:89860983-89860984 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
34 | rs111611999 | chr5:89861005-89861006 | Weak transcription Enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
35 | rs528657338 | chr5:89861070-89861071 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
36 | rs547549315 | chr5:89861125-89861126 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
37 | rs567365476 | chr5:89861129-89861130 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
38 | rs536305288 | chr5:89861146-89861147 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
39 | rs193147811 | chr5:89861175-89861176 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
40 | rs552221518 | chr5:89861180-89861181 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
41 | rs569515366 | chr5:89861202-89861203 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
42 | rs533099597 | chr5:89861213-89861214 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
43 | rs474800 | chr5:89861312-89861313 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
44 | rs558547687 | chr5:89861399-89861400 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs112105918 | chr5:89861403-89861404 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs623761 | chr5:89861410-89861411 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
47 | rs78096756 | chr5:89861438-89861439 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs537159557 | chr5:89861475-89861476 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs12332756 | chr5:89861613-89861614 | Weak transcription ZNF genes & repeats Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs12332758 | chr5:89861639-89861640 | Weak transcription ZNF genes & repeats Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 22032731 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Prostate cancer | 21965145 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Testicular cancer | 18059402 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Mental retardation | 19592390 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Mental retardation | 19471318 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:89855200-89871000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr5:89856200-89860400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
3 | chr5:89856600-89860200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
4 | chr5:89856600-89860400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
5 | chr5:89858400-89860200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
6 | chr5:89859000-89861600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr5:89859200-89861000 | Enhancers | H9 Cell Line | embryonic stem cell |
8 | chr5:89859400-89864200 | Weak transcription | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
9 | chr5:89859400-89884200 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
10 | chr5:89859600-89860200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
11 | chr5:89859600-89860400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
12 | chr5:89859600-89860600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
13 | chr5:89859800-89860200 | Enhancers | Brain Germinal Matrix | brain |
14 | chr5:89859800-89862000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
15 | chr5:89860200-89861200 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
16 | chr5:89860200-89868000 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
17 | chr5:89860400-89862600 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
18 | chr5:89860600-89861000 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
19 | chr5:89861000-89861800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
20 | chr5:89861000-89862200 | Weak transcription | H9 Cell Line | embryonic stem cell |
21 | chr5:89861200-89861800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
22 | chr5:89861600-89861800 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |